(2591 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Nasal allergen challenge
-
Bronchial allergen challenge in research
-
Delabelling adults
-
Bronchial allergen challenge in the clinic
-
Living with food allergy
-
How do allergens sensitize?
-
Danger signs
-
Adherence: A challenge for Immunotherapy
-
New and clinically relevant contact allergens
-
Update on drug allergy
-
Novel pharamacological targets
-
Oral food challenges thresholds for clinical reactions
-
Food allergy - the beginners guide
-
Allergy to Kale
-
Food allergy: new allergens on the block
-
Epithelial cell barrier and allergic diseases
-
An update on food allergy
-
Immune modulation in local allergic rhinitis
-
Novel approaches of allergen immunotherapy
-
The dilemma of food allergy additives
-
Environmental epigenomics of allergy
-
Novel cell based assays in allergy diagnostics
-
Oral food challenge versus biomarkers - are challenges still needed?
-
Neuroimmunology and allergy
-
Therapies for multiple-tree nut allergies
-
Differential diagnosis
-
Launch of the Biological guidelines
-
Over-the-counter allergy prevention weaning products
-
An update on prevention of allergic diseases
-
Tackling anaphylaxis
-
Asma e alergia em Angola
-
Skin care from birth for allergy prevention: results today
-
Prevention of food allergy: where are we now?
-
New insights in urticaria mechanisms
-
May contain traces… management in children with food allergies
-
E-cigarettes: mechanistic link to lung injury
-
Allergen immunotherapy for food allergy
-
Asma e alergia em pandemia
-
Impact of climate change on the immune system
-
Route of exposure determines the immune response to food allergens
-
Urban green spaces - The exposure and allergenicity index
-
Mechanisms of non IgE mediated food allergy
-
Novel insight into development of allergic diseases
-
Vaccines for older adults: benefits and limitations
-
Allergen immunotherapy: nasal allergen vs chamber challenges vs other tests
-
Allergenicity and IgE recognition of new Dau c 1 allergens from carrot
-
Diagnosis of insect venom allergy: back to basics
-
Understanding parent preferences for paediatric allergy services
-
Evidence of immunotherapy on allergy prevention?
-
Epitope mapping of the major allergen 2S albumin from pine nut
-
Big changes in asthma treatment : GINA 2019
-
Impact of climate change on asthma exacerbations
-
Is anaphylaxis really rare in children?
-
AI models
-
Can the birch pollen be more aggressive in the polluted environments?
-
Measles infection causes immune amnesia
-
Can group consultations work in allergy? Learning from rheumatology
-
Linking bovine milk components and their possible association with allergic diseases
-
Implementing component resolved diagnostics in allergy diagnosis
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
How to improve outcomes
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Airborne enzymes – New and re-emerging occupational hazards
-
Treating allergic patients during the COVID-19 pandemic
-
Pru p 10: the polygalacturonase described as a new peach tree pollen allergen
-
Can we prevent the development of food allergy?
-
Asthma: phenotypes to endotypes
-
Virtual care, social media and mHealth for allergy management
-
Wild-fires, pollution, climate change and other threats
-
Tree nut allergy: path from national to global data
-
Towards vaccination of birch pollen and birch pollen-associated food allergy
-
Molecular allergology in daily clinical practice
-
New perspectives for anaphylaxis
-
Should we do patch testing in children with eczema?
-
Primary care in CRDs during COVID
-
Covid-19 in "Allergy" journal
-
Developing an adolescent and young adult allergy service
-
BAT in clinical practice. Is it possible?
-
Desensitization in chemotherapy and biologics
-
Moisturisers for the primary prevention of food allergy
-
Cellular tests for the diagnosing and monitoring of allergy
-
Unmet needs in immunological mechanisms in AIT: key cellular playersView Presentation
-
AAAAI Practice Parameters
-
Component Resolved Diagnosis and pollen Immunotherapy indication
-
Phenotypes and Endotypes
-
Challenges on the implementation of early introduction of allergenic foods
-
Vaccines- Is this the tool to end the pandemic?
-
Structural biology of food allergens and cross reactivity
-
Personalized nutrition approach towards better QOL in Food Allergy
-
Non-T2 directed biologicals
-
Alternative free-from foods to reach a balanced diet
-
Molecular and structural considerations for aerosolization of food allergens
-
Predicting adverse reactions to biologicals
-
Gut microbiome and histamine signal in pathogenesis of IBD
-
How to improve compliance of allergen immunotherapy in the clinic?
-
Practical approach of diagnosis and management of not IgE mediated food allergies
-
Psychological support to peanut allergic children and their families
-
Immunological basis of food aversion
-
Mental health needs and access to care among patients with food allergy
-
Understanding immunological mechanisms that confer a higher risk of allergy
-
The ‘allergy tool kit’ for the transition clinic
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Risk assessment and active management of food allergy
-
Difficult to control asthma in children
-
A cohort study into intravenous drug provocation tests in perioperative allergy
-
Precision Medicine and AIT
-
Autoimmunity in atopic diseases
-
Anti IL4/13 and IL33/TSLP
-
Lessons learned from immune tolerance approaches to target allergic diseases: an NIAD’s perspective
-
Immune regulation in specific B cells in food allergy, tolerance and outgrowing children
-
Mechanism and prevention of epicutaneous sensitization to food allergens
-
The clinical clues and pitfalls in contact dermatitis
-
Precision medicine in immunodeficiency
-
Basophil activation tests and allergy to COVID-19 vaccines
-
What do we learn from subgroup analyses in phase-III trials?
-
ÖGAI: Covid as best practice model to combine immunology and allergy
-
Do adrenaline auto-injectors save lives?
-
Cow’s milk protein-induced allergic proctocolitis: cohort review
-
Role Viral reactivations
-
Sleep patterns and development of children with atopic dermatitis
-
Elderly asthma
-
Microbiota in immune-based therapies
-
Role of antigen-presenting cells in tolerance and allergy
-
EAACI Guidelines on environmental health
-
Sustained unresponsiveness to tree nuts after low dose oral immunotherapy in children aged 9-24 months
-
Epicutaneous immunotherapy for the treatment of food allergy: ready for the prime time?
-
BAT as a diagnostic tool in allergy to lipid transfer proteins (LTP)
-
Occupational respiratory allergy in food processing industries
-
MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing
-
New visions for managing anaphylaxis. Lesson from EAACI guidelines
-
Viral infection and asthma
-
The engineering-medicine interface
-
When to evaluate children with atopic dermatitis for Type IV allergy
-
Social media and Allergies: how can we support our patients?
-
How can we improve the quality of life of patients with severe food allergy?
-
What is the immunological basis for new biologicals?
-
What’s different about the adolescent brain?
-
Anaphylaxis in ICD-11
-
Bronchiectasis and severe asthma
-
The role of metalloproteinase 9 in the pathogenesis of atopic dermatitis in children
-
B cell tolerance: an essential mechanism for allergen immunotherapy in house dust mite allergy
-
COVID-19 and virus-induced asthma in children: Asian vs western perspectives
-
Flare-up phenomenon of Sars-CoV2 vaccine secondary to epicutaneous test with polyethylene glycol
-
Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
-
The concept of AllergoOncology: understanding the potential of IgE Antibodies in cancer
-
Cow's milk allergy guidelines promote over-diagnosis of milk allergy (Pro & Con Session: Con)
-
Cow's milk allergy guidelines promote over-diagnosis of milk allergy (Pro & Con Session: Pro)
-
T cell-based laboratory tests for diagnosis in clinical practice?
-
Clinical manifestations of severe cutaneous adverse drug reaction
-
Telemedicine and Tele-health
-
Can we identify patients at risk of life-threatening allergic reaction to food?
-
Management of adverse reactions to biologics
-
Immune response to Corona virus infection
-
Drug reactions of the skin or Novel mechanisms of drug reactions
-
How to evaluate lung function? Hands-on plus lecture
-
Development of a childhood asthma prediction model using machine learning approaches
-
Outcome measures for adult’s vs children in the clinic during allergen immunotherapy
-
Entre US y Europa. La Experiencia de la Inmunoterapia en Mexico
-
Efficacy and safety of ragweed SLIT-tablet from a large trial in children with allergic rhinoconjunctivitis
-
When hives are not chronic urticaria
-
Pathophysiology and diagnostic innovation in ocular allergy
-
Does human milk and its composition matter for development and prevention of allergies?
-
The underlying immunology of pruritus
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
Lung function testing
-
Phenotypes and endotypes of occupational allergy
-
Should we use partial allergen sequence information for food allergy risk assessment?
-
The brain, nose, immune axis
-
Environment and Immunology StandUp TalksSpeakers ...
-
Using BAT for differentiation between sensitization and allergy to alpha-gal
-
Hologenome and obesity
-
Metabolome-wide association study (MWAS) in subjects with self-reported beta-lactam allergic reactions using the twinsUK cohort
-
The clinical burden of cow’s milk allergy in childhood – a retrospective cohort study
-
Probiotics and prebiotics: an on-going journey
-
Food industry perspective
-
Basophil activation test results change in birch pollen sensitized patients during first season of immunotherapy
-
Contact urticaria and protein contact dermatitis connecting skin and airways
-
Elevated tryptase – Now what?
-
Precision medicine and biomarkers of atopic dermatitis
-
How to select and follow a biological for asthma and CRSwNP
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
Prescribing immunotherapy to pollens in children: influence of geographical and sociological diversity
-
How to use social media in your professional practice: the clinician perspective
-
Inflammatory biomarkers
-
Recognizing immediate reactions in contact dermatitis
-
Fully functional PIPEline IgE, IgG1 and IgG4 against the major birch pollen allergen Bet v 1: Proof of concept in cellular assays
-
Air pollution and allergy: call for action!
-
AIT, Biologicals and Covid vaccination
-
Impact of food allergy on household expenditures among Manitoba families
-
Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
The trajectory of immune development in early life and its association with clinical allergic disease outcomes
-
Flexible and rigid dendrimer-based nanostructures for cell effector studies in the context of amoxicillin allergy
-
Preparing a grant: Dos and Don'ts
-
Is There A Place For Chlorhexidine In The European Baseline Series?
-
B cells in in chronic rhinosinusitis: friend or foe
-
Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments
-
Global impact of the COVID-19 on the environment
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
Hypersensitivity to antiepileptic drugs
-
Dynamic and Behavior of plane tree pollen and its relationship with Pla a 1 aeroallergen concentration in Évora (Portugal)
-
Endotype-driven treatment in chronic rhinosinusitis
-
Influence of antigen density and TLR ligands on efficacy of a VLP-based vaccine against Peanut Allergy: mechanistic insights
-
We are what we eat - importance of food to health, moving past simple calories
-
Trichinella spiralis infection associated with chronic spontaneous urticaria - case series
-
A patient with an acute reaction: recognize, document and treat
-
Late onset T2 asthma – a case study
-
Eosinophilic fasciitis, an unusual presentation
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Gut microbiome - based therapeutic approaches
-
Optimization of allergen immunotherapy care using an integrated eHealth environment
-
Asthma management during the COVID-19 pandemics
-
FAAM-EUROBAT Opening ceremony
-
Unusual presentations of contact dermatitis
-
Electronic Health in Severe Asthma
-
How to keep a child with anaphylaxis safe in school
-
Immunotherapy in severe asthma (AIT)
-
Pediatric Asthma in Real Life (PeARL): addressing controversies in pediatric asthma
-
Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy
-
Hand eczema during the COVID-19 pandemic
-
Immune responses in desentitization and tolerance
-
Eosinophil ETosis, a cytolytic degranulation and diseases
-
Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy
-
Interferon therapy in airway disease: prophylaxis is the new approach in exacerbation prevention?
-
Basophil sensitivity during immunotherapy in grass pollen-allergic patients
-
A system biology and machine learning approach to childhood asthma
-
Covid 19 and air pollution: is there a relationship?
-
Targeted approaches for asthma
-
The role of infection in chronic spontaneous urticaria
-
Healthcare use and asthma control among overweight/obese urban children sensitized and exposed to classroom allergens
-
Recognition of synthetic antigenic determinants of clavulanic acid in patients with immediate allergic reactions to beta-lactams using lymphocyte transformation test
-
Impacting quality of life with PALFORZIA
-
Human and computational models of immune mediated inflammatory skin disease: challenges, insights and perspectives
-
Early biomarkers for severe drug hypersensitivity reactions
-
Big data and cluster analysis: a real life perspective
-
Good safety profile, efficacy and few withdrawals during oral immunotherapy with characterised GMP peanut protein in a real-world setting
-
Evaluation of platelet to lymphocyte ratio (PLR) in various types of hypersensitivity to NSAIDs
-
Algorithm for evaluation of cutaneous manifestations of drug hypersensitivities
-
Systematic review and meta-analyses on the accuracy of diagnostic tests for IgE-mediated food allergy
-
Potential usefulness of in-vitro tools for identifying aeroallergens sensitization in suspected local allergic rhinitis
-
Identification of optimal cut-off points for nasal volumes and symptoms score in the assessment of the outcome of the nasal allergen challenge
-
Assessment of efficacy of allergen immunotherapy in patients with allergic rhinitis and atopic asthma
-
Efficacy and safety of epicutaneous immunotherapy (EPIT) for peanut allergy in subjects with and without concomitant food allergies
-
Pediatric Covid-19 highlights published in PAI in 2020
-
Tezepelumab (anti-TSLP) in asthma
-
Why is a transition clinic needed for adolescents and young adults (AYA) with allergy and asthma?
-
Collective advocacy for action on CRDs
-
MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study
-
Update of the WAO anaphylaxis guidance
-
Efficacy of venom immunotherapy: How long should patients be treated?
-
A controlled naturalistic approach to the study of allergic conjunctivitis (AC) in an environmental exposure chamber (EEC)
-
Ligelizumab (anti-IgE) in chronic spontaneous urticaria
-
Biologicals in allergy and asthma: A deep learning approach to optimized patient management
-
GINA Guidelines Update
-
Extensively hydrolysed formula with two human milk oligosaccharides reduces rate of upper respiratory tract infections in infants with cow’s milk allergy
-
Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases
-
When is it not a food allergy? Dietary approaches to the diagnosis of histamine intolerance
-
Potential role of mir-185-5P as feedback mechanism for controlling airway remodeling and smooth muscle contraction
-
Drug provocation test in non-immediate beta-lactam hypersensitivity workup: One-day vs prolonged protocol in pediatric patients
-
Impaired olfaction: diagnostics and its role in diseases
-
Is IgA a piece of the EoE puzzle?
-
Innate trained immunity: An evolutionary perspective
-
Integrated systems biology strategies for diagnostics and immune monitoring in allergy
-
Getting the diagnosis right is essential for optimal nutritional and dietary management of food allergy
-
Implementing biomarkers in immunophenotyping of atopic dermatitis
-
Management of CRS: Highlights of EPOS 2020
-
Management of CRS: Highlights of EPOS 2020
-
Focus on Patient. Personalised therapy for severe asthma
-
Cow’s milk allergy can be monitored through the degree of competition between specific IgE and IgG
-
Allergen immunotherapy for rhinitis phenotypes other than allergic rhinitis: mixed rhinitis and local allergic rhinitis
-
Fast acting disruptive IgE inhibitors rapidly desensitize allergic effector cells and resolve IgE-mediated anaphylaxis
-
Scraping nasal cytology in the diagnostics of the respiratory tract diseases
-
AIT in the pediatric population
-
Skin test, drug provocation and laboratory tests: which ones and when?
-
Difficult to control asthma in adults
-
Precision medicine and biomarkers in chronic rhinosinusitis with nasal polyps
-
